San Francisco, CA, United States of America

Florian Lempp

This inventor holds 1 USPTO granted patent. Top assignee: Universitat Heidelberg. Active years: 2023.


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Florian Lempp: Innovator in Hepatitis D Virus Detection

Introduction

Florian Lempp is a notable inventor based in San Francisco, CA (US). He has made significant contributions to the field of medical diagnostics, particularly in the detection of hepatitis D virus (HDV) infections. His innovative work has the potential to improve patient outcomes through rapid and accurate diagnosis.

Latest Patents

Florian Lempp holds a patent for a method and means for the rapid detection of HDV infections. The patent describes a polypeptide and a nucleic acid encoding the polypeptide for use in detecting the presence of hepatitis D virus and diagnosing HDV infections. This invention also includes an in vitro method, an immunographic test device, and a kit designed for point-of-care diagnostics for HDV infections. He has 1 patent to his name.

Career Highlights

Florian Lempp is associated with Universitat Heidelberg, where he has been involved in groundbreaking research. His work focuses on developing diagnostic tools that can be utilized in clinical settings to enhance the detection and monitoring of viral infections.

Collaborations

Florian collaborates with Stephan Urban, who is also a prominent figure in the field of hepatitis research. Their partnership aims to advance the understanding and treatment of HDV infections.

Conclusion

Florian Lempp's contributions to the field of medical diagnostics, particularly in the detection of hepatitis D virus, highlight his innovative spirit and dedication to improving healthcare. His work is paving the way for more effective diagnostic methods that can significantly impact patient care.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…